Refine Holdings Co Ltd
Records under this name other than the patents Refine Holdings Co Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Back to Refine Holdings Co Ltd
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,721,070 | Translating Multifocal Eyeglass Lenses now held by Essilor International In force · High confidence | In force | High confidence | |
| US 9,549,804 | Nonaugmentive Mastopexy now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Jan 24, 2025 · High confidence | Lapsed on the fee record | Ended Jan 24, 2025 | High confidence |
| US 10,595,985 | Minimally Invasive Breast Lift Method with a Superior Tissue Support and an Inferior Anchor now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Mar 24, 2024 · High confidence | Lapsed on the fee record | Ended Mar 24, 2024 | High confidence |
| US 9,220,589 | Minimally Invasive Breast Lift Method with a Superior Tissue Support and an Inferior Anchor now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Dec 29, 2023 · High confidence | Lapsed on the fee record | Ended Dec 29, 2023 | High confidence |
| US 7,837,613 | Minimally Invasive Breast Lift Method with a Superior Tissue Support and an Inferior Anchor now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Nov 23, 2022 · High confidence | Lapsed on the fee record | Ended Nov 23, 2022 | High confidence |
| US 10,092,384 | Nonaugmentive Mastopexy Lapsed on the fee record Ended Oct 9, 2022 · High confidence | Lapsed on the fee record | Ended Oct 9, 2022 | High confidence |
| US 10,039,857 | Minimally Invasive Tissue Support now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Aug 7, 2022 · High confidence | Lapsed on the fee record | Ended Aug 7, 2022 | High confidence |
| US 8,632,454 | Minimally Invasive Tissue Support System and Method with a Superior Tissue Support and an Inferior Anchor now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Jan 21, 2022 · High confidence | Lapsed on the fee record | Ended Jan 21, 2022 | High confidence |
| US 9,763,770 | Minimally Invasive Breast Lift Method with a Superior Tissue Support and an Inferior Anchor now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Sep 19, 2021 · High confidence | Lapsed on the fee record | Ended Sep 19, 2021 | High confidence |
| US 8,480,557 | Nonaugmentive Mastopexy now held by Sinclair Pharmaceuticals Limited Lapsed on the fee record Ended Jul 9, 2021 · High confidence | Lapsed on the fee record | Ended Jul 9, 2021 | High confidence |